Shares of BioNTech (NASDAQ: BNTX) are down 2.5% in pre-market after UBS analyst Eliana Merle reiterated a Neutral rating but ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)
网页链接Shares of BioNTech (NASDAQ: BNTX) are down 2.5% in pre-market after UBS analyst Eliana Merle reiterated a Neutral rating but ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)
网页链接
精彩评论